BlackRock Inc. - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 45 filers reported holding LIANBIO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$916,630
-59.6%
615,188
-38.3%
0.00%
Q2 2023$2,271,662
+13.3%
996,343
-2.6%
0.00%
Q1 2023$2,005,289
+19.5%
1,023,1070.0%0.00%
Q4 2022$1,677,895
-18.0%
1,023,1070.0%0.00%
Q3 2022$2,046,000
-8.2%
1,023,107
-0.9%
0.00%
Q2 2022$2,229,000
-34.2%
1,032,083
+87.7%
0.00%
Q4 2021$3,388,000550,0000.00%
Other shareholders
LIANBIO shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$4,929,0004.16%
Perceptive Advisors 56,560,211$122,170,0003.83%
SCHF (GPE), LLC 937,500$2,025,0002.99%
VR Adviser, LLC 5,378,341$11,617,0002.29%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$7,159,0000.52%
Affinity Asset Advisors, LLC 450,000$972,0000.41%
Altium Capital Management LP 315,191$681,0000.27%
RA Capital Management 4,622,574$9,985,0000.27%
22NW, LP 141,223$305,0000.16%
Logos Global Management LP 394,486$852,0000.16%
View complete list of LIANBIO shareholders